Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126179451 | 12617945 | 1 | I | 20150202 | 20160726 | 20160803 | 20160803 | EXP | CH-SM-2016-06146 | CH-BAYER-2016-145167 | BAYER | 86.00 | YR | E | F | Y | 0.00000 | 20160803 | MD | CH | CH |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126179451 | 12617945 | 1 | PS | Aspirin Cardio | ASPIRIN | 1 | Oral | 100 MG, QD | 21317 | 100 | MG | COATED TABLET | QD | ||||||
126179451 | 12617945 | 2 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 20 MG, UNK | 0 | 20 | MG | ||||||||
126179451 | 12617945 | 3 | SS | KCL-RETARD | POTASSIUM CHLORIDE | 1 | Oral | 10 MMOL, QD | 0 | 10 | MMOL | QD | |||||||
126179451 | 12617945 | 4 | SS | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 25 MG, BID | 0 | 25 | MG | BID | |||||||
126179451 | 12617945 | 5 | C | MST CONTINUS | MORPHINE SULFATE | 1 | Oral | 10 MG, BID | 0 | 10 | MG | BID | |||||||
126179451 | 12617945 | 6 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | Oral | 1 DF, BID | 0 | 1 | DF | BID | |||||||
126179451 | 12617945 | 7 | C | DOMPERIDONE | DOMPERIDONE | 1 | Oral | 10 MG, TID | 0 | 10 | MG | TID | |||||||
126179451 | 12617945 | 8 | C | METOLAZONE. | METOLAZONE | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
126179451 | 12617945 | 9 | C | AMLODIPIN | AMLODIPINE BESYLATE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
126179451 | 12617945 | 10 | C | TEMESTA | LORAZEPAM | 1 | 1 MG, QD | 0 | 1 | MG | QD | ||||||||
126179451 | 12617945 | 11 | C | TARDYFERON | FERROUS SULFATE | 1 | Oral | 1 DF, BID | 0 | 1 | DF | BID | |||||||
126179451 | 12617945 | 12 | C | TORASEMID SANDOZ | TORSEMIDE | 1 | Oral | 200 MG, QD | 0 | 200 | MG | QD | |||||||
126179451 | 12617945 | 13 | C | PANTOZOL | PANTOPRAZOLE SODIUM | 1 | Oral | 40 MG, QD | 0 | 40 | MG | QD | |||||||
126179451 | 12617945 | 14 | C | RAMIPRIL. | RAMIPRIL | 1 | Oral | 5 MG, QD | 0 | 5 | MG | QD | |||||||
126179451 | 12617945 | 15 | C | ELTROXIN | LEVOTHYROXINE | 1 | Oral | .05 MG, QD | 0 | .05 | MG | QD | |||||||
126179451 | 12617945 | 16 | C | MORPHINI | MORPHINE HYDROCHLORIDE | 1 | Oral | 4 ML, TID | 0 | 4 | ML | TID | |||||||
126179451 | 12617945 | 17 | C | NOVALGIN | METAMIZOLE SODIUM | 1 | Oral | 20 GTT, QID | 0 | 20 | GTT | QID | |||||||
126179451 | 12617945 | 18 | C | VI-DE 3 | CHOLECALCIFEROL | 1 | Oral | 20 GTT, QD | 0 | 20 | GTT | QD | |||||||
126179451 | 12617945 | 19 | C | IMPORTAL | LACTITOL | 1 | Oral | 20 ML, BID | 0 | 20 | ML | BID | |||||||
126179451 | 12617945 | 20 | C | MOVICOL | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | Oral | 1 DF, QOD | 0 | 1 | DF | QOD |
Indications of drugs used
no results found |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126179451 | 12617945 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126179451 | 12617945 | Abdominal pain | |
126179451 | 12617945 | Death | |
126179451 | 12617945 | Haematemesis |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |